151 related articles for article (PubMed ID: 15217613)
1. The anticancer natural product pironetin selectively targets Lys352 of alpha-tubulin.
Usui T; Watanabe H; Nakayama H; Tada Y; Kanoh N; Kondoh M; Asao T; Takio K; Watanabe H; Nishikawa K; Kitahara T; Osada H
Chem Biol; 2004 Jun; 11(6):799-806. PubMed ID: 15217613
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis induction via microtubule disassembly by an antitumour compound, pironetin.
Kondoh M; Usui T; Nishikiori T; Mayumi T; Osada H
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):411-6. PubMed ID: 10333483
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules.
Marco JA; García-Pla J; Carda M; Murga J; Falomir E; Trigili C; Notararigo S; Díaz JF; Barasoain I
Eur J Med Chem; 2011 May; 46(5):1630-7. PubMed ID: 21396747
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of truncated α-tubulin-binding pironetin analogues lacking alkyl pendants in the side chain or the dihydropyrone ring.
Paños J; Díaz-Oltra S; Sánchez-Peris M; García-Pla J; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Org Biomol Chem; 2013 Sep; 11(35):5809-26. PubMed ID: 23892508
[TBL] [Abstract][Full Text] [Related]
5. Studies of (-)-pironetin binding to α-tubulin: conformation, docking, and molecular dynamics.
Bañuelos-Hernández AE; Mendoza-Espinoza JA; Pereda-Miranda R; Cerda-García-Rojas CM
J Org Chem; 2014 May; 79(9):3752-64. PubMed ID: 24761989
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
Yoshida M; Matsui Y; Ikarashi Y; Usui T; Osada H; Wakasugi H
Anticancer Res; 2007; 27(2):729-36. PubMed ID: 17465195
[TBL] [Abstract][Full Text] [Related]
7. Pironetin Binds Covalently to αCys316 and Perturbs a Major Loop and Helix of α-Tubulin to Inhibit Microtubule Formation.
Prota AE; Setter J; Waight AB; Bargsten K; Murga J; Diaz JF; Steinmetz MO
J Mol Biol; 2016 Jul; 428(15):2981-8. PubMed ID: 27395016
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Cytotoxicity Evaluation of C4- and C5-Modified Analogues of the α,β-Unsaturated Lactone of Pironetin.
Huang DS; Wong HL; Georg GI
ChemMedChem; 2017 Apr; 12(7):520-528. PubMed ID: 28261964
[TBL] [Abstract][Full Text] [Related]
9. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of C2 functionalized analogs of the α-tubulin-binding natural product pironetin.
Huang DS; Wong HL; Georg GI
Bioorg Med Chem Lett; 2018 Sep; 28(16):2789-2793. PubMed ID: 29138028
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of pironetin and related analogs: studies on structure-activity relationships as tubulin assembly inhibitors.
Watanabe H; Watanabe H; Usui T; Kondoh M; Osada H; Kitahara T
J Antibiot (Tokyo); 2000 May; 53(5):540-5. PubMed ID: 10908119
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of pironetin analogue/colchicine hybrids and study of their cytotoxic activity and mechanisms of interaction with tubulin.
Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
J Med Chem; 2014 Dec; 57(24):10391-403. PubMed ID: 25426924
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of simplified pironetin analogues with modifications in the side chain and the lactone ring.
Roldán S; Cardona A; Conesa L; Murga J; Falomir E; Carda M; Marco JA
Org Biomol Chem; 2016 Dec; 15(1):220-232. PubMed ID: 27901163
[TBL] [Abstract][Full Text] [Related]
14. Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule.
Yang J; Wang Y; Wang T; Jiang J; Botting CH; Liu H; Chen Q; Yang J; Naismith JH; Zhu X; Chen L
Nat Commun; 2016 Jun; 7():12103. PubMed ID: 27357539
[TBL] [Abstract][Full Text] [Related]
15. The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin.
Torijano-Gutiérrez S; Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Arch Pharm (Weinheim); 2015 Aug; 348(8):541-7. PubMed ID: 26085125
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.
Neugebauer RC; Uchiechowska U; Meier R; Hruby H; Valkov V; Verdin E; Sippl W; Jung M
J Med Chem; 2008 Mar; 51(5):1203-13. PubMed ID: 18269226
[TBL] [Abstract][Full Text] [Related]
17. Revisiting microtubule targeting agents: α-Tubulin and the pironetin binding site as unexplored targets for cancer therapeutics.
Coulup SK; Georg GI
Bioorg Med Chem Lett; 2019 Aug; 29(15):1865-1873. PubMed ID: 31130264
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
[TBL] [Abstract][Full Text] [Related]
19. Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues.
Vergoten G; Bailly C
Plants (Basel); 2023 Jan; 12(2):. PubMed ID: 36679009
[TBL] [Abstract][Full Text] [Related]
20. Tubulin photoaffinity labeling with biotin-tagged derivatives of potent diketopiperazine antimicrotubule agents.
Yamazaki Y; Kohno K; Yasui H; Kiso Y; Akamatsu M; Nicholson B; Deyanat-Yazdi G; Neuteboom S; Potts B; Lloyd GK; Hayashi Y
Chembiochem; 2008 Dec; 9(18):3074-81. PubMed ID: 19012291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
